More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Press Releases
    • Media Coverage
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Press Releases
    • Media Coverage

Medical Marijuana, Inc. CEO Dr. Stuart Titus Talks Science of Cannabinoids with YEW Media

by Eve Ripley | May 17, 2017 | Company News, Media Coverage

[vc_row][vc_column][vc_column_text] Dr. Stuart Titus appeared on podcast Yew Media yesterday to discuss cannabinoid research and share the many successes that Medical Marijuana, Inc. has achieved in recent months. Radio personality Chris Cantore recently invited...

Medical Marijuana, Inc. Welcomes New Vice President of Data & Technology, Dirk Syburra

by Eve Ripley | Jan 17, 2017 | HempMeds, Kannaway, Press Releases

SAN DIEGO, Jan. 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Dirk Syburra has been promoted to Vice President of Data & Technology for the company....

Medical Marijuana, Inc. Investment AXIM® Biotech Receives Positive PK Data Results for CanChew Plus(R) CBD Gum

by Eve Ripley | Jan 9, 2017 | Axim Biotechnologies, Press Releases

AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing Gum SAN DIEGO, CA — (Marketwired) — 01/09/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded...

Article Names Medical Marijuana, Inc. and AXIM® Biotech as Two of “10 Largest Marijuana Companies Raking in Huge Profits”

by Eve Ripley | Jan 6, 2017 | Axim Biotechnologies, Press Releases

SAN DIEGO, CA — (Marketwired) — 01/06/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured in a recent High Times article, “10 Largest...

AXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD Gum

by Eve Ripley | Jan 4, 2017 | Axim Biotechnologies, Press Releases

NEW YORK – Jan. 04, 2017 – AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, and gears up for clinical trial on alleviating...
« Older Entries

POPULAR

  • Medical Marijuana, Inc. Closes with Lotus Capital for a $2 Million Equity Based Line of Credit CanChew Dixie Botanicals
  • Can Cannabidiol (CBD) Fight Metastatic Cancer? According to the latest research the answer is yes. Dixie Botanicals Red Dice Holdings
  • Medical Marijuana Inc. Dixie Elixirs and Edibles Brand Lands October 22 Front Page Cover Story of Newsweek Dixie Botanicals
  • Medical Marijuana Inc. Announces Wholesale Distribution Sales Program for Dixie X CBD Hemp Wellness Product Line Dixie Botanicals
  • Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of New Flavored CBD Vape Liquids

LAST NEWS

  • Photo Release — Hemp in the Wind: HempMeds Supports Chicago Cannabis Conference as Platinum Sponsor
  • Medical Marijuana, Inc. CEO to Speak at Hemp for the Future Event in Reykjavík, Iceland
  • Leading News Feature Website Medium Features Medical Marijuana, Inc. Subsidiary HempMeds® Spokesperson Liz Carmouche
  • Medical Marijuana, Inc. and Subsidiary Kannaway® Announce August 2018 as the Largest Sales Month in Company History
  • Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Temple University

Subscribe for Company Updates

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.